Title: Michael Brisco: Innovator in Clonal Cell Characterization Introduction Michael Brisco is an accomplished inventor based in Australia. He has made significant contributions to the field of molecular biology, particularly in the characterization of clonal cells. His innovative work has the potential to impact various medical applications. Latest Patents Michael Brisco holds a patent titled "Identification Of Clonal Cells By Repeats In T-Cell Receptor And Immunoglobulin V/D/J Genes." This invention relates to a method of characterizing a nucleic acid region, specifically focusing on analyzing a marker nucleic acid region. The method is based on identifying one or both of the nucleic acid regions flanking a marker nucleic acid region. This approach provides a means of analyzing a marker nucleic acid region that is characteristic of a clonal population of cells. The invention is particularly useful for monitoring the progression of conditions characterized by clonal populations of cells, such as neoplastic conditions. It also aids in predicting the likelihood of a subject's relapse from a remissive state to a disease state, assessing the effectiveness of existing therapeutic drugs, and identifying the presence of a marker region. Career Highlights Michael Brisco is associated with Monoquant Pty Ltd, where he applies his expertise in molecular biology. His work at the company focuses on advancing the understanding of clonal cell populations and their implications in various medical conditions. Despite having no patents listed under his name, his contributions to the field are noteworthy. Collaborations Michael collaborates with notable colleagues, including Alexander Alan Morley and Pamela Sykes. These partnerships enhance the research and development efforts at Monoquant Pty Ltd, fostering innovation in the field of clonal cell characterization. Conclusion Michael Brisco is a dedicated inventor whose work in the identification of clonal cells has the potential to revolutionize medical diagnostics and treatment strategies. His contributions, although currently limited in patent count, reflect a commitment to advancing scientific knowledge and improving patient outcomes.

Growing community of inventors

AU

Michael Brisco